The Ministry of Health of the Russian Federation registered the drug “ZolgenSma” in Russia, according to the Pharmaceutical Bulletin, with reference to the data of the State Register of Medicines.
Medicine manufacturer – Swiss pharmaceutical company Novartis – filed documents for registration in July 2020.
“Zolgenma” is used to treat spinal muscular atrophy (SM). This drug is considered the most expensive in the world. One of his injection costs more than two million dollars. The medicine is injected into the body once.